|
|
||||||||
From the Department of Medicine, University of Toronto, Ontario, Canada (Dr. Edmeads); Servicio de Neurologia, Hospital Clínico General Universitario, Valencia, Spain (Dr. Láinez); The Neurology Group, Nashville, TN (Dr. Brandes); CHR de la Citadelle, Liège, Belgium (Dr. Schoenen); Diamond Headache Clinic and the Diamond Headache Inpatient Treatment Unit, Catholic Health Partners, Columbus Hospital; and Finch University of Health Sciences/Chicago Medical School, Midwestern University/Chicago College of Osteopathic Medicine, Chicago, IL (Dr. Freitag).
Address correspondence and reprint requests to Dr. John Edmeads, Department of Medicine, Sunnybrook and Womens College, Sunnybrook Campus, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5. e-mail: John.Edmeads{at}swchsc.on.ca
Migraine is not always well managed in clinical practice, often being under-diagnosed and under-treated. As a result, many sufferers never consult a physician or lapse from care after physician contact. Although most migraine care is provided by general practitioners, others, including specialists, emergency room physicians, pharmacists, and alternative practitioners, may also be involved. A method of standardizing clinical information about migraine is essential for coordinated, logical, and systematic care. The impact of migraine on the patient is an important clinical parameter but one that is seldom inquired about, perhaps because it exhibits such marked variability among and within individuals. Headache-related disability can be an objective and measurable index of this impact. The Migraine Disability Assessment (MIDAS) Questionnaire is a simple and validated instrument with potential for use in clinical practice, research, and public health. It can improve communication between patients and health-care professionals regarding the impact of migraine which, in turn, allows tailoring of the intensity of treatment to the severity of the illness. Changes in the MIDAS score may serve as an end point in assessing treatment efficacy. In populations, MIDAS scores may indicate the burden of migraine in the community and spark public health initiatives to improve management.
This article has been cited by other articles:
![]() |
A. D. Hershey, S. W. Powers, A.-L. B. Vockell, S. LeCates, M.A. Kabbouche, and M. K. Maynard PedMIDAS: Development of a questionnaire to assess disability of migraines in children Neurology, December 11, 2001; 57(11): 2034 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Lipton, W. F. Stewart, and P. J. Goadsby Headache-related disability in the management of migraine Neurology, March 1, 2001; 56(suppl_1): S1 - S3. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |